Overview Retatrutide is a synthetic, long-acting triple agonist that targets three distinct hormonal receptors: the glucagon-like pep-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor (GCGR)
For most people, the tiredness peaks during initial adjustment weeks and after dose increases, then improves substantially within 3 to 4 weeks
Check with your pharmacist for more details about the brand you use
Both can be supplemented safely alongside GLP-1 medications, but should be taken at least 4 hours away from levothyroxine to avoid absorption interference
Various factors, including individual health, diet, exercise habits, and metabolic changes, can contribute to any observed changes in menstruation
Most patients experience these effects as temporary and manageable, though individual responses vary